field brief · no. 002 · comparator
Ethnobotanical
Where blue lotus sits
01
Taxonomic ground truth
family · genus · species| blue lotus | Nymphaea caerulea Savigny · Nymphaeaceae |
|---|---|
| sacred / Asian lotus | Nelumbo nucifera Gaertn. · Nelumbonaceae |
| damiana | Turnera diffusa Willd. · Passifloraceae |
| kanna | Sceletium tortuosum (L.) N.E.Br. · Aizoaceae |
| mugwort | Artemisia vulgaris L. · Asteraceae |
| passionflower | Passiflora incarnata L. · Passifloraceae |
| key point | Blue lotus and sacred lotus share a name. They share one alkaloid (nuciferine). They are in different plant families. |
why the confusion persists
"Lotus" is a 4,000-year-old English vernacular with no botanical anchor. Egyptian art uses the blue water lily as the "sacred lotus of the Nile"; Asian iconography uses Nelumbo nucifera as "sacred lotus." Vendors and casual readers routinely conflate them. The alkaloid overlap is one compound (nuciferine); the receptor profiles diverge.
02
Alkaloid profile matrix
primary · secondary · claimed| species | primary alkaloid(s) | class | target | evidence tier |
|---|---|---|---|---|
| N. caerulea | nuciferine · aporphine | aporphine | D1/D2 antagonist · 5-HT2A partial | in vitro + animal |
| N. caerulea | apomorphine · aporphine | aporphine | D2 agonist · 5-HT2A | in vitro · no controlled human flower-dose data |
| Nelumbo nucifera | nuciferine · liensinine · neferine | aporphine + bisbenzylisoquinoline | adrenergic + Ca-channel | in vitro · animal · traditional use |
| Turnera diffusa | apigenin · pinocembrin · damianin (tincture) | flavonoids + arbutin | GABA-A modulation (proposed) | traditional use · weak in vitro |
| Sceletium tortuosum | mesembrine · mesembrenone | Sceletium alkaloids | SERT inhibitor (PDE4 too) | animal + small human trial (Zembrin®) |
| Artemisia vulgaris | thujone (trace) · flavonoids · coumarins | monoterpene + phenolics | GABA-A (thujone) · anti-inflammatory | traditional use · in vitro |
| Passiflora incarnata | chrysin · vitexin · harmala alkaloids (trace) | flavonoids + β-carbolines | GABA-A modulation | small RCTs · anxiolytic indication |
Sources: PMC 10609367 (blue lotus composition) · Wie et al 2021 (Nelumbo) · ACS Lab · Superpower · Zembrin® phase III data · Brown et al 2018 (Sceletium). This table describes in-vitro and animal receptor activity, not human subjective effect at any specific dose.
03
Route × species matrix
how people actually use these| species | common routes | typical dose range | onset | duration |
|---|---|---|---|---|
| N. caerulea | smoke · vapor · tea · wine maceration · tincture | 1–10 g dried petal (oral) · 0.25–0.5 g (inhaled) | 5–20 min oral · 30–120 s inhaled | 1–3 h oral · 20–45 min inhaled |
| Nelumbo nucifera | tea · soup · lotus seed paste · incense (not inhalation) | 5–15 g dried leaf | 30–60 min oral | 2–4 h oral |
| Turnera diffusa | tea · tincture · smoke (occasionally) | 2–4 g dried leaf | 30–45 min oral | 1–2 h oral |
| Sceletium tortuosum | sublingual · tea · capsule (Zembrin®) | 50–100 mg standardized extract | 30–60 min | 3–6 h |
| Artemisia vulgaris | smoke · tea · moxibustion | 1–3 g dried leaf | 1–5 min inhaled · 20–40 min oral | 15–45 min inhaled · 2–3 h oral |
| Passiflora incarnata | tea · tincture · capsule | 0.5–2 g dried leaf | 30–60 min | 1–3 h |
Doses are ranges drawn from traditional use reports, vendor guidance, and where available small clinical studies — not controlled trial data. Inhalation doses are 5–20× smaller than oral for the same plant.
04
Cultural record
where each shows up in art, ritual, and commerce| species | documented use | form / vehicle | modern commercial status |
|---|---|---|---|
| N. caerulea | Egyptian art, 14th c. BCE · Tutankhamun garlands (1922) · Mayan frescoes | wine infusion · ritual offering | smokeable flower · vape liquid · tea · wine (US/EU/most of world) |
| Nelumbo nucifera | Hindu / Buddhist iconography · Chinese medicine · Vietnamese cuisine | seed paste · tea · temple offering | food ingredient · tea · supplement (legal, regulated) |
| Turnera diffusa | Maya · early 19th c. US patent medicine ("damiana cordials") | tea · liqueur (historic) | tea · tincture · vape additive · supplement |
| Sceletium tortuosum | Khoisan pastoralists · 17th c. European ethnobotany | chewed fermented · tea | standardized extract (Zembrin®) · tea · vape (newer) |
| Artemisia vulgaris | European folk medicine · TCM (艾叶) · pre-Christian midsummer | moxibustion · tea · dream pillow | tea · incense · supplement |
| Passiflora incarnata | Aztec · colonial American eclectic medicine · 19th c. Europe (Grasse) | tea · tincture | tea · standardized extract · anxiolytic OTC in EU |
05
Where the comparison breaks
claims that don't transfer- "Blue lotus gets you high like cannabis." False. The receptor profile (D1/D2 antagonist + 5-HT2A partial) is closer to atypical antipsychotics than to THC. Subjective reports describe relaxation and dream enhancement, not intoxication.
- "Sacred lotus and blue lotus are the same plant." False — different families, different alkaloid profiles, only nuciferine shared. They occupy different ethnomedical niches.
- "Kanna is the closest pharmacological cousin to blue lotus." Partially true. Mesembrine (Sceletium) is a SERT inhibitor — closer to an SSRI mechanism than to aporphine. They pair well but aren't equivalents.
- "Damiana has aporphine alkaloids." False. Damiana's chemistry is flavonoid + arbutin + pinocembrin; it doesn't share a class with blue lotus.
- "All of these are legal everywhere." False. Kanna is regulated in some EU states (novel food); passionflower is regulated for OTC anxiolytics; mugwort thujone content is regulated under EU flavoring law. Always check current jurisdiction.
- "This table tells you how to dose blue lotus from the others." False. The matrix is mechanistic comparison, not equivalence. The canonical blue-lotus dose ladder lives at /dose-card/.